Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
Version 3 2024-06-18, 16:54
Version 2 2024-06-05, 08:22
Version 1 2019-09-01, 00:00
journal contribution
posted on 2024-06-18, 16:54 authored by R Sethi, N Gómez-Coronado, Adam Walker, OD Robertson, B Agustini, Michael BerkMichael Berk, Seetal DoddSeetal DoddNeurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
History
Related Materials
- 1.
Location
SwitzerlandOpen access
- Yes
Link to full text
Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2019, Sethi, Gómez-Coronado, Walker, Robertson, Agustini, Berk and Dodd.Journal
Frontiers in PsychiatryVolume
10Article number
ARTN 605Pagination
1 - 21ISSN
1664-0640eISSN
1664-0640Publisher
FRONTIERS MEDIA SAUsage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicinePsychiatrydepressionbipolar disorderschizophreniaobsessive compulsive disorderautism spectrum disorderpsychiatryinflammationcyclooxygenase-2 inhibitorsC-REACTIVE PROTEINMAJOR DEPRESSIVE DISORDEROBSESSIVE-COMPULSIVE DISORDERRANDOMIZED DOUBLE-BLINDTO-MODERATE DEPRESSIONAUTISM SPECTRUM DISORDERSNECROSIS-FACTOR-ALPHAADJUNCTIVE CELECOXIB TREATMENTSCHIZOPHRENIA CLINICAL STATUSINTERFERON-INDUCED DEPRESSION110999 Neurosciences not elsewhere classified920410 Mental HealthSchool of MedicineFaculty of HealthInnovation in Mental and Physical Health and Clinical Treatment3209 Neurosciences3214 Pharmacology and pharmaceutical sciences
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC